ATRX and central nervous system cancer: Nevertheless, HOXA5, PTPN2, WT1, HOXD10, POSTN, ADAMDEC1 and MYBPH were overexpressed in ATRX-mt glioma tissues with high-risk scores compared with low-risk scores (Figure 7G).